Document is current

Article History

Accepted: 9 March 2021

First Online: 7 May 2021

Declarations

:

: V. Garla declares no conflict of interest.J. Butler reports being a consultant for Abbott, Adrenomed, Amgen, Applied Therapeutics, Array, AstraZeneca, Bayer, Boehringer Ingelheim, CVRx, G3 Pharma, Impulse Dynamics, Innolife, Janssen, LivaNova, Luitpold, Medtronic, Merck, Novartis, NovoNordisk, Relypsa, Sequana Medical, V-Wave Limited, and Vifor, outside the submitted work.L. F. Lien reports other from Merck, Eli Lilly and Company, Sanofi-Aventis, and Tandem, outside the submitted work. She is also Editor/Author of a textbook (Lien LF, Cox ME, Feinglos MN, Corsino L. (eds.) <i>Glycemic Control in the Hospitalized Patient, First Edition.</i> New York: Springer, 2010), and she receives royalties from Springer.

: This article does not contain any studies with human or animal subjects performed by any of the authors.